Download FREE Report Sample
Download Free sampleThe loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels.
Erectile Dysfunction Market contains market size and forecasts of Erectile Dysfunction in Global, including the following market information:
Global Erectile Dysfunction Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Erectile Dysfunction market was valued at 4995.6 million in 2021 and is projected to reach US$ 7328.5 million by 2028, at a CAGR of 5.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ED Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erectile Dysfunction include Eli Lilly, Pfizer, Bayer, Boston Scientific, Coloplast, Apricus Biosciences, Cristalia Produtos Quimicos Farmaceuticos, Dong-A Socio and Endo Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erectile Dysfunction companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erectile Dysfunction Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Erectile Dysfunction Market Segment Percentages, by Type, 2021 (%)
ED Drugs
ED Devices
Global Erectile Dysfunction Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Erectile Dysfunction Market Segment Percentages, by Application, 2021 (%)
Congenital Patients
Pathological Patients
Global Erectile Dysfunction Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Erectile Dysfunction Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erectile Dysfunction revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Erectile Dysfunction revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Pfizer
Bayer
Boston Scientific
Coloplast
Apricus Biosciences
Cristalia Produtos Quimicos Farmaceuticos
Dong-A Socio
Endo Pharmaceuticals
Futura Medical
Meda Pharmaceuticals
Promedon
SK Chemical
Teva Pharmaceuticals
Vivus
Zephyr Surgical Implants (ZSI)
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy